Moreover, treatment with a combination of Celecoxib and DCN markedly inhibits EMT and proliferation of colorectal cancer cells in DCN−/− mice and it is proposed as a potential adjuvant protein therapy [63]. Here, DCN is linked to colorectal cancer.